Viewing nowTelito Tablet 40mg (Telmisartan)
Telmisartan 40mg
Tablet · Prescription medication
Boryung BioPharma Co., Ltd.

MFDS item code 201901726 · Approved 2019.03.22 · Insurance code 670501460
Treatment of essential hypertension; prevention of cardiovascular disease in high-risk patients
This medication is used for the treatment of essential hypertension. It also helps reduce the risk of cardiovascular diseases such as coronary artery disease, stroke, and peripheral artery disease in patients over 55 years of age who are unable to use ACE inhibitors. It is particularly effective in lowering the risk of myocardial infarction, stroke, and death due to cardiovascular diseases. Therefore, this medication plays an important role not only in managing hypertension but also in preventing cardiovascular complications. It is used to improve patients' cardiovascular health and reduce disease risk.
1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water, with or without food. For some patients, 20 mg once daily may be effective. If necessary, the dose may be increased to 80 mg once daily. The maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment when the dose is increased. This medicine has an additional blood pressure-lowering effect when coadministered with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that 80 mg of this medicine be administered orally once daily with water, with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.
This medication can cause serious harm to the fetus and newborn during pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. It should not be used in individuals allergic to this medication or its components, women who are pregnant or breastfeeding, patients with severe liver impairment, certain hereditary angioedema patients, and patients with diabetes or severe kidney dysfunction. Elderly patients or those with hyperkalemia, mild to moderate liver dysfunction, heart valve disease, gastrointestinal disorders, or renal artery hypertension should use this medication cautiously and consult healthcare professionals before administration. While taking this medication, various adverse reactions may occur, including infection, hypotension, liver dysfunction, renal impairment, angioedema, hyperkalemia, interstitial pneumonia, and rhabdomyolysis, so patients should inform their healthcare provider immediately if symptoms occur. In particular, if rapid drops in blood pressure, dizziness, fainting, difficulty breathing, or swelling of the face or lips occur, immediate medical attention should be sought. This medication may interact with other antihypertensive medications or specific drugs, so patients should inform their healthcare provider of any other medications they are taking. Patients with poor renal function should regularly check their serum potassium and creatinine levels, and those with reduced blood volume should be cautious of hypotension risk. Patients undergoing surgery should ideally discontinue this medication 24 hours before the procedure. This medication contains sorbitol; it should not be taken by patients with fructose intolerance. Caution should be exercised while driving or operating dangerous machinery as dizziness or fainting may occur. Safety and efficacy in pediatric patients under 18 years of age have not been established, and use is not recommended. In case of overdose, hypotension, abnormal heart rate, dizziness, and acute renal failure may occur, so the prescribed dosage should be strictly observed, and the patient should immediately visit a hospital if any abnormal symptoms arise. This medication should be stored out of reach of children, and transferring it to another container is not advisable for maintaining its quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. It is best maintained at room temperature between 1 to 30 degrees Celsius to ensure the safety of the medication's effectiveness.
White or almost white, bilayered, convex, round tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowTelmisartan 40mg
Tablet · Prescription medication
Boryung BioPharma Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Boehringer Ingelheim Korea Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Kwangdong Pharmaceutical Co., Ltd.

Telmisartan 40mg
Tablet · Prescription medication
Sam-il Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Samil Pharmaceutical Co., Ltd.

Telmisartan 80mg
Tablet · Prescription medication
Genewon Science Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.